Direct binding of DNA by tumor suppressor menin

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Menin is a tumor suppressor protein implicated in Multiple Endocrine Neoplasia type I (MEN1).
• Menin's biochemical function and direct DNA-binding capabilities remain largely uncharacterized.
• Understanding menin's mechanism is critical for deciphering MEN1 pathogenesis.

Purpose of the Study:

• To investigate whether menin directly binds DNA.
• To identify the regions and residues of menin responsible for DNA binding.
• To correlate menin's DNA binding activity with its tumor suppressor functions.

Main Methods:

• Electrophoretic mobility shift assays (EMSAs) to assess DNA binding.
• Site-directed mutagenesis to probe protein regions involved in DNA binding.
• Cell proliferation and cell cycle assays (G2/M phase) to evaluate functional consequences.

Main Results:

• Menin directly binds double-stranded DNA and various DNA structures (Y-structures, branched, 4-way junctions).
• The COOH terminus of menin mediates DNA binding; MEN1-associated mutations in this region abolish binding.
• Mutations affecting positively charged residues in nuclear localization signals impair DNA binding and cell proliferation repression.

Conclusions:

• Menin possesses a novel, direct DNA-binding biochemical activity.
• Menin's DNA binding, mediated by its COOH terminus and nuclear localization signals, is essential for its tumor suppressor function.
• Disruption of menin's DNA binding by MEN1 mutations explains the loss of cell proliferation control in MEN1.